IBIO Latest Press Releases

-- November 24, 2025 --

iBio to Participate in the 8th Annual Evercore Healthcare Conference Globe Newswire 4:15 PM

-- November 12, 2025 --

iBio Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update Globe Newswire 4:01 PM

-- October 30, 2025 --

iBio Unveils New Non-Human Primate Data on IBIO-610, an Activin E Antibody with Strong Therapeutic Potential for Fat-Selective Weight-Loss and Weight Maintenance Globe Newswire 7:00 AM

-- October 23, 2025 --

iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference Globe Newswire 7:00 AM

-- October 21, 2025 --

iBio to Present New Preclinical Data on Its Activin E Antibody at Two Upcoming Scientific Conferences, ObesityWeek and PEGS Europe 2025 Globe Newswire 7:00 AM

-- September 5, 2025 --

iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update Globe Newswire 7:30 AM

-- August 25, 2025 --

iBio Announces Closing of $50 Million Public Offering Globe Newswire 7:00 AM

-- August 19, 2025 --

iBio Announces Pricing of $50 Million Public Offering Globe Newswire 8:01 AM

-- August 18, 2025 --

iBio Announces Proposed Public Offering Globe Newswire 4:01 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software